相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Unmet needs in the treatment of rheumatoid arthritis. An observational study and a real-life experience from a single university center
Evripidis Kaltsonoudis et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)
Fostamatinib for the treatment of immune thrombocytopenia in adults
Donald C. Moore et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2019)
Efficacy and Safety of Multiple Dosages of Fostamatinib in Adult Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Yaqi Kang et al.
FRONTIERS IN PHARMACOLOGY (2019)
MiR-377 mediates the expression of Syk to attenuate atherosclerosis lesion development in ApoE-/- mice
Yinsheng Guo et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Cardiovascular Safety During Treatment With Baricitinib in Rheumatoid Arthritis
Peter C. Taylor et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Long-term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program
James B. Bussel et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials
James Bussel et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Inflammatory Arthritis and Heart Disease
Santos Castaneda et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
Splenic tyrosine kinase (SYK) inhibitors and their possible use in acute myeloid leukemia
Sushma Bartaula-Brevik et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2018)
Update on Cardiovascular Disease Risk in Patients with Rheumatic Diseases
Rachel H. Mackey et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2018)
Increased Burden of Psychiatric Disorders in Rheumatoid Arthritis
Ruth Ann Marrie et al.
ARTHRITIS CARE & RESEARCH (2018)
A Clinical Update and Global Economic Burden of Rheumatoid Arthritis
Syed Ali Fazal et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2018)
Fostamatinib, an oral spleen tyrosine kinase inhibitor, in the treatment of rheumatoid arthritis: a meta-analysis of randomized controlled trials
Sumit Kunwar et al.
RHEUMATOLOGY INTERNATIONAL (2016)
Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis
Eva Salgado et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Getting Syk: spleen tyrosine kinase as a therapeutic target
Robert L. Geahlen
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
An Oral Syk Kinase Inhibitor in the Treatment of Rheumatoid Arthritis A Three-Month Randomized, Placebo-Controlled, Phase II Study in Patients With Active Rheumatoid Arthritis That Did Not Respond to Biologic Agents
Mark C. Genovese et al.
ARTHRITIS AND RHEUMATISM (2011)
The Syk kinase as a therapeutic target in leukemia and lymphoma
Dimitar G. Efremov et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Rheumatoid arthritis
Loreto Carmona et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2010)
Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia
Jonathan W. Friedberg et al.
BLOOD (2010)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Treatment of Rheumatoid Arthritis With a Syk Kinase Inhibitor A Twelve-Week, Randomized, Placebo-Controlled Trial
Michael E. Weinblatt et al.
ARTHRITIS AND RHEUMATISM (2008)
Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor
Polly R. Pine et al.
CLINICAL IMMUNOLOGY (2007)
Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs
Attila Mocsai et al.
NATURE IMMUNOLOGY (2006)
R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation
Sylvia Braselmann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Induction and suppression of collagen-induced arthritis is dependent on distinct Fcγ receptors
S Kleinau et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
